Authors

Latest:

Dr. Durand Discusses Treatment Options for Toxicities from Therapy in HER2+ Breast Cancer

Jean-Bernard Durand, MD, professor in the Department of Cardiology at The University of Texas MD Anderson Cancer Center, discusses advice for community oncologists on managing patients that are experiencing symptoms from treatment for HER2-positive breast cancer.

Jean Bourhis, MD, PhD

Latest:

Dr. Bourhis on the OS Benefit of Xevinapant Plus Chemoradiotherapy in HNSCC

Jean Bourhis, MD, PhD, discusses the overall survival benefit of xevinapant plus chemoradiotherapy in head and neck squamous cell carcinoma.

Jean Hoffman-Censits, MD

Latest:

Dr. Hoffman-Censits Discusses the Future Treatment of Bladder Cancer

Jean Hoffman-Censits, MD, associate professor of Medical Oncology, Thomas Jefferson University Hospital, Sidney Kimmel Cancer Center, discusses the future treatment landscape of bladder cancer.

Jean Hurteau, MD

Latest:

Dr. Jean Hurteau on Diagnosing Ovarian Clear Cell Carcinoma

Jean Hurteau, MD, professor, Division of Gynecologic Oncology at NorthShore University Health System, discusses the difficulties of diagnosing ovarian clear cell carcinoma. Hurteau says data for the diagnosis of the carcinoma is older, and is not relevant to contemporary diagnoses due to the fact that there were more mixed tumors previously than there are now.

Jean Jacques Grob, MD, PhD

Latest:

Dr. Grob on the Tolerability and Efficacy of Ipilimumab in Melanoma

Jean Jacques Grob, MD, PhD, professor of dermatology at the Hospital de la Timone, discusses the tolerability and efficacy of ipilimumab (Yervoy) for melanoma.

Jean-Jacques Kiladjian, MD, PhD, Saint-Louis Hospital (AP-HP)

Latest:

Dr. Kiladjian on Improving Transfusion-Independence Rates With Momelotinib in Myelofibrosis

Jean-Jacques Kiladjian, MD, PhD, discusses the potential utility of momelotinib in improving transfusion-independence rates in myelofibrosis.

Jean L. Koff, MD, MS

Latest:

Dr Koff on Frontine and Maintenance Treatment Decision-Making in MCL

Jean L. Koff, MD, MS, discusses factors that influence treatment decision-making for patients with MCL in the frontline and maintenance settings.

Jean Lopategui, MD

Latest:

Dr. Lopategui on the Evolution of Targeted Therapies in NSCLC

Jean Lopategui, MD, discusses the evolution of targeted therapies in non–small cell lung cancer.

Jean-Pascal Machiels, MD

Latest:

Dr. Machiels on Challenges and Ongoing Trials in Head and Neck Cancer

Jean-Pascal Machiels, MD, head of the Department of Medical Oncology, Cliniques Universitaires Sain-Luc, discusses challenges still facing the field of head and neck cancer and ongoing trials with a goal to improve patient outcomes.

Jean Weigert, MD

Latest:

Dr. Weigert on Cancer Screening for Women With Dense Breasts

Jean Wright, MD

Latest:

Dr. Wright on the Benefit of Moderate Hypofractionation in Early-Stage Breast Cancer

Jean Wright, MD, discusses the benefit of moderate hypofractionation in patients for adjuvant radiotherapy in patients with early-stage breast cancer.

Jean-Yves Blay, MD, PhD

Latest:

Dr. Blay on Treatment Considerations in Soft Tissue Sarcomas

Jean-Yves Blay, MD, discusses treatment considerations in patients with soft tissue sarcomas.

Jean-Yves Blay, MD, PhD, Centre Leon Berard

Jeanine Stiles

Latest:

Jeanine Stiles on the Importance of Supportive Care for Patients With Cancer

Jeanine Stiles, chief administrative officer, associate director for administration, UC Davis Comprehensive Cancer Center, discusses the importance of supportive care for patients with cancer.

Jeanne M. Palmer, MD

Latest:

Myeloproliferative Neoplasm Management: Future Directions in Care

Closing out their discussion on myeloproliferative neoplasms, key opinion leaders share excitement for future evolutions in the treatment paradigm.

Jeannette Y. Wick, RPh, MBA

Latest:

New Therapies for Prostate Cancer: The Practicalities

Now, with four new agents approved in the last two years and two promising agents in the pipeline, therapy selection and potential outcomes are changing.

Jeannie Chern, MD

Latest:

Dr. Chern on Challenges Regarding Germline Testing in Ovarian Cancer

Jeannie Chern, MD, discusses challenges with germline molecular testing for patients with ovarian cancer.

Jeannine Brant, PhD, APRN, AOCN

Latest:

Jeannine Brant on the Benefits of Patient-Reported Outcomes

Jeannine Brant, PhD, Billings Clinic, discusses the benefits of patient-reported outcomes in cancer care.

Jed A. Katzel, MD

Latest:

Dr. Katzel on Differences in Therapy Between Men and Women With Head and Neck Cancer

Jed A. Katzel, MD, Hematology, Kaiser Permanente Santa Clara Medical Center, discusses differences in treatment decisions between men and women with head and neck cancer.

Jed Katzel, MD

Latest:

Dr. Katzel on Women Being Undertreated for Head and Neck Cancer

Jed Katzel, MD, Hematology, Kaiser Permanente Santa Clara Medical Center, discusses research presented at the 2018 ASCO Annual Meeting, which evaluated whether women are undertreated for head and neck cancer.